id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-D-0222-0004,FDA,FDA-2002-D-0222,GUIDANCE,Supporting & Related Material,GDL-Guidance,2003-12-08T05:00:00Z,2003,12,,,2008-04-12T01:17:30Z,,0,0,0900006480497116
FDA-2002-D-0222-0005,FDA,FDA-2002-D-0222,GUIDANCE,Supporting & Related Material,GDL-Guidance,2003-12-08T05:00:00Z,2003,12,,,2008-04-12T01:17:30Z,,0,0,0900006480497117
FDA-2002-D-0222-0003,FDA,FDA-2002-D-0222,FDA,Notice,NAD-Notice of Availability of Data,2003-12-08T05:00:00Z,2003,12,2003-11-20T05:00:00Z,,2008-04-12T01:17:30Z,,0,0,0900006480497115